Aurobindo Pharma Limited has informed the Exchange that Record date for the purpose of Buyback is 17-Apr-2026.
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma's Board has approved a buyback of up to 54,23,728 equity shares (0.93% of paid-up capital) at INR 1,475 per share, totaling up to INR 800 crores. The buyback represents 3.93% and 2.62% of standalone and consolidated free reserves respectively. The record date for determining eligible shareholders is April 17, 2026. The buyback will be conducted via tender offer route and is open to all shareholders including promoters, subject to regulatory approvals.
The buyback at INR 1,475 per share signals management confidence and provides a price floor for the stock. Shareholders who tender will receive cash at a significant premium to face value, while those who hold may benefit from increased share value due to reduced share count.